pharmacists as part of an "early warning system" to help identify problems with newly approved drugs
November 2000
You'll hear about a proposal to rely more on pharmacists as part of an "early warning system" to help identify problems with newly approved drugs.
In the last three years, the FDA has had to take seven drugs off the market...Rezulin, Propulsid, Redux, Pondimin, Posicor, Seldane, and Duract.
The FDA currently relies on voluntary reports to monitor new drugs for adverse reactions.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote